Follow CAP on Social Media

Listen to the CAP Podcast

More Than Half a Billion Doses of Chinese Vaccines Will be Manufactured Overseas Every Year

Image via Bridge Consulting.

Chinese pharmaceutical companies have finalized production licensing agreements with seven countries around the world that will enable the production of just under 600 million COVID-19 vaccine doses every year, according to data from Bridge.

Bridge notes that at this point the manufacturing process is quite simple, with these production facilities largely re-packaging bulk quantities of vaccine ingredients imported from China, rather than making any vaccines from scratch.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?

Independent

The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.